 | • レポートコード：C9J09963 • 出版社/出版日：Prof Research / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥450,000 (USD3,000) | ▷ お問い合わせ |
| Site License | ￥570,000 (USD3,800) | ▷ お問い合わせ |
| Global Site License | ￥750,000 (USD5,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 世界及び中国における閉経後骨粗鬆症薬市場について調査・分析したレポートで、閉経後骨粗鬆症薬の世界市場動向、市場規模、主要企業情報などが含まれています。閉経後骨粗鬆症薬の種類別・用途別に分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中国などに区分してまとめてあります。 ・閉経後骨粗鬆症薬産業の概要 ・閉経後骨粗鬆症薬の製造技術分析 ・主要企業分析：企業概要、製品情報、連絡先など ・世界及び中国の閉経後骨粗鬆症薬市場 2014年-2019年 ・世界及び中国の閉経後骨粗鬆症薬市場現状 ・企業別分析：Eli Lilly, Amgen, Merck, Novartis, Allergan, Amgen Astellas Biopharm, Deltanoid Pharmaceuticals, Noven, Novo Nordisk, Osteologix, Pfizer, PhytoHealth, Radius Health, Tarsa Therapeutics, UCB, Uni-Bio Sなど ・地域別分析：アメリカ、ヨーロッパ、日本、中国など ・種類別分析、用途別分析 ・世界及び中国の閉経後骨粗鬆症薬市場予測 2019年-2024年 ・閉経後骨粗鬆症薬の産業チェーン分析 ・世界及び中国のマクロ経済動向と影響 ・世界及び中国の閉経後骨粗鬆症薬市場動向・課題・機会 ・新規プロジェクトへの提言・結論 |
Postmenopausal Osteoporosis Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Postmenopausal Osteoporosis Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Postmenopausal Osteoporosis Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Postmenopausal Osteoporosis Drug market covering all important parameters.
The key ponits of the report:
1.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
2.The report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.
3.Through the statistical analysis, the report depicts the global and Chinese total market of Postmenopausal Osteoporosis Drug industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report then estimates 2019-2024 market development trends of Postmenopausal Osteoporosis Drug industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.
6.The report makes some important proposals for a new project of Postmenopausal Osteoporosis Drug Industry before evaluating its feasibility.
There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.
For competitor segment, the report includes global key players of Postmenopausal Osteoporosis Drug as well as some small players. At least 16 companies are included:
* Eli Lilly
* Amgen
* Merck
* Novartis
* Allergan
* Amgen Astellas Biopharm
For complete companies list, please ask for sample pages.
The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share
For product type segment, this report listed main product type of Postmenopausal Osteoporosis Drug market in gloabal and china.
* Product Type I
* Product Type II
* Product Type III
For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.
* Application I
* Application II
* Application III
Reasons to Purchase this Report:
* Estimates 2019-2024 Postmenopausal Osteoporosis Drug market development trends with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
Any special requirements about this report, please let us know and we can provide custom report.
レポート目次Chapter One Introduction of Postmenopausal Osteoporosis Drug Industry
1.1 Brief Introduction of Postmenopausal Osteoporosis Drug
1.2 Development of Postmenopausal Osteoporosis Drug Industry
1.3 Status of Postmenopausal Osteoporosis Drug Industry
Chapter Two Manufacturing Technology of Postmenopausal Osteoporosis Drug
2.1 Development of Postmenopausal Osteoporosis Drug Manufacturing Technology
2.2 Analysis of Postmenopausal Osteoporosis Drug Manufacturing Technology
2.3 Trends of Postmenopausal Osteoporosis Drug Manufacturing Technology
Chapter Three Analysis of Global Key Manufacturers
3.1 Eli Lilly
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 2014-2019 Production Information
3.1.4 Contact Information
3.2 Amgen
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 2014-2019 Production Information
3.2.4 Contact Information
3.3 Merck
3.2.1 Company Profile
3.3.2 Product Information
3.3.3 2014-2019 Production Information
3.3.4 Contact Information
3.4 Novartis
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 2014-2019 Production Information
3.4.4 Contact Information
3.5 Allergan
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 2014-2019 Production Information
3.5.4 Contact Information
3.6 Amgen Astellas Biopharm
3.6.1 Company Profile
3.6.2 Product Information
3.5.3 2014-2019 Production Information
3.6.4 Contact Information
3.7 Deltanoid Pharmaceuticals
3.7.1 Company Profile
3.7.2 Product Information
3.7.3 2014-2019 Production Information
3.7.4 Contact Information
3.8 Company H
3.8.1 Company Profile
3.8.2 Product Information
3.8.3 2014-2019 Production Information
3.8.4 Contact Information
……
……
Chapter Four 2014-2019 Global and Chinese Market of Postmenopausal Osteoporosis Drug
4.1 2014-2019 Global Capacity, Production and Production Value of Postmenopausal Osteoporosis Drug Industry
4.2 2014-2019 Global Cost and Profit of Postmenopausal Osteoporosis Drug Industry
4.3 Market Comparison of Global and Chinese Postmenopausal Osteoporosis Drug Industry
4.4 2014-2019 Global and Chinese Supply and Consumption of Postmenopausal Osteoporosis Drug
4.5 2014-2019 Chinese Import and Export of Postmenopausal Osteoporosis Drug
Chapter Five Market Status of Postmenopausal Osteoporosis Drug Industry
5.1 Market Competition of Postmenopausal Osteoporosis Drug Industry by Company
5.2 Market Competition of Postmenopausal Osteoporosis Drug Industry by Country (USA, EU, Japan, Chinese etc.)
5.3 Market Analysis of Postmenopausal Osteoporosis Drug Consumption by Application/Type
Chapter Six 2019-2024 Market Forecast of Global and Chinese Postmenopausal Osteoporosis Drug Industry
6.1 2019-2024 Global and Chinese Capacity, Production, and Production Value of Postmenopausal Osteoporosis Drug
6.2 2019-2024 Postmenopausal Osteoporosis Drug Industry Cost and Profit Estimation
6.3 2019-2024 Global and Chinese Market Share of Postmenopausal Osteoporosis Drug
6.4 2019-2024 Global and Chinese Supply and Consumption of Postmenopausal Osteoporosis Drug
6.5 2019-2024 Chinese Import and Export of Postmenopausal Osteoporosis Drug
Chapter Seven Analysis of Postmenopausal Osteoporosis Drug Industry Chain
7.1 Industry Chain Structure
7.2 Upstream Raw Materials
7.3 Downstream Industry
Chapter Eight Global and Chinese Economic Impact on Postmenopausal Osteoporosis Drug Industry
8.1 Global and Chinese Macroeconomic Environment Analysis
8.1.1 Global Macroeconomic Analysis
8.1.2 Chinese Macroeconomic Analysis
8.2 Global and Chinese Macroeconomic Environment Development Trend
8.2.1 Global Macroeconomic Outlook
8.2.2 Chinese Macroeconomic Outlook
8.3 Effects to Postmenopausal Osteoporosis Drug Industry
Chapter Nine Market Dynamics of Postmenopausal Osteoporosis Drug Industry
9.1 Postmenopausal Osteoporosis Drug Industry News
9.2 Postmenopausal Osteoporosis Drug Industry Development Challenges
9.3 Postmenopausal Osteoporosis Drug Industry Development Opportunities
Chapter Ten Proposals for New Project
10.1 Market Entry Strategies
10.2 Countermeasures of Economic Impact
10.3 Marketing Channels
10.4 Feasibility Studies of New Project Investment
Chapter Eleven Research Conclusions of Global and Chinese Postmenopausal Osteoporosis Drug Industry
Tables and Figures
Figure Postmenopausal Osteoporosis Drug Product Picture
Table Development of Postmenopausal Osteoporosis Drug Manufacturing Technology
Figure Manufacturing Process of Postmenopausal Osteoporosis Drug
Table Trends of Postmenopausal Osteoporosis Drug Manufacturing Technology
Figure Postmenopausal Osteoporosis Drug Product and Specifications
Table 2014-2019 Postmenopausal Osteoporosis Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Postmenopausal Osteoporosis Drug Capacity Production and Growth Rate
Figure 2014-2019 Postmenopausal Osteoporosis Drug Production Global Market Share
Figure Postmenopausal Osteoporosis Drug Product and Specifications
Table 2014-2019 Postmenopausal Osteoporosis Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Postmenopausal Osteoporosis Drug Capacity Production and Growth Rate
Figure 2014-2019 Postmenopausal Osteoporosis Drug Production Global Market Share
Figure Postmenopausal Osteoporosis Drug Product and Specifications
Table 2014-2019 Postmenopausal Osteoporosis Drug Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Postmenopausal Osteoporosis Drug Capacity Production and Growth Rate
Figure 2014-2019 Postmenopausal Osteoporosis Drug Production Global Market Share
Figure Postmenopausal Osteoporosis Drug Product and Specifications
Table 2014-2019 Postmenopausal Osteoporosis Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Postmenopausal Osteoporosis Drug Capacity Production and Growth Rate
Figure 2014-2019 Postmenopausal Osteoporosis Drug Production Global Market Share
Figure Postmenopausal Osteoporosis Drug Product and Specifications
Table 2014-2019 Postmenopausal Osteoporosis Drug Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Postmenopausal Osteoporosis Drug Capacity Production and Growth Rate
Figure 2014-2019 Postmenopausal Osteoporosis Drug Production Global Market Share
Figure Postmenopausal Osteoporosis Drug Product and Specifications
Table 2014-2019 Postmenopausal Osteoporosis Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Postmenopausal Osteoporosis Drug Capacity Production and Growth Rate
Figure 2014-2019 Postmenopausal Osteoporosis Drug Production Global Market Share
Figure Postmenopausal Osteoporosis Drug Product and Specifications
Table 2014-2019 Postmenopausal Osteoporosis Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Postmenopausal Osteoporosis Drug Capacity Production and Growth Rate
Figure 2014-2019 Postmenopausal Osteoporosis Drug Production Global Market Share
Figure Postmenopausal Osteoporosis Drug Product and Specifications
Table 2014-2019 Postmenopausal Osteoporosis Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Postmenopausal Osteoporosis Drug Capacity Production and Growth Rate
Figure 2014-2019 Postmenopausal Osteoporosis Drug Production Global Market Share
……
……
Table 2014-2019 Global Postmenopausal Osteoporosis Drug Capacity List
Table 2014-2019 Global Postmenopausal Osteoporosis Drug Key Manufacturers Capacity Share List
Figure 2014-2019 Global Postmenopausal Osteoporosis Drug Manufacturers Capacity Share
Table 2014-2019 Global Postmenopausal Osteoporosis Drug Key Manufacturers Production List
Table 2014-2019 Global Postmenopausal Osteoporosis Drug Key Manufacturers Production Share List
Figure 2014-2019 Global Postmenopausal Osteoporosis Drug Manufacturers Production Share
Figure 2014-2019 Global Postmenopausal Osteoporosis Drug Capacity Production and Growth Rate
Table 2014-2019 Global Postmenopausal Osteoporosis Drug Key Manufacturers Production Value List
Figure 2014-2019 Global Postmenopausal Osteoporosis Drug Production Value and Growth Rate
Table 2014-2019 Global Postmenopausal Osteoporosis Drug Key Manufacturers Production Value Share List
Figure 2014-2019 Global Postmenopausal Osteoporosis Drug Manufacturers Production Value Share
Table 2014-2019 Global Postmenopausal Osteoporosis Drug Capacity Production Cost Profit and Gross Margin List
Figure 2014-2019 Chinese Share of Global Postmenopausal Osteoporosis Drug Production
Table 2014-2019 Global Supply and Consumption of Postmenopausal Osteoporosis Drug
Table 2014-2019 Import and Export of Postmenopausal Osteoporosis Drug
Figure 2018 Global Postmenopausal Osteoporosis Drug Key Manufacturers Capacity Market Share
Figure 2018 Global Postmenopausal Osteoporosis Drug Key Manufacturers Production Market Share
Figure 2018 Global Postmenopausal Osteoporosis Drug Key Manufacturers Production Value Market Share
Table 2014-2019 Global Postmenopausal Osteoporosis Drug Key Countries Capacity List
Figure 2014-2019 Global Postmenopausal Osteoporosis Drug Key Countries Capacity
Table 2014-2019 Global Postmenopausal Osteoporosis Drug Key Countries Capacity Share List
Figure 2014-2019 Global Postmenopausal Osteoporosis Drug Key Countries Capacity Share
Table 2014-2019 Global Postmenopausal Osteoporosis Drug Key Countries Production List
Figure 2014-2019 Global Postmenopausal Osteoporosis Drug Key Countries Production
Table 2014-2019 Global Postmenopausal Osteoporosis Drug Key Countries Production Share List
Figure 2014-2019 Global Postmenopausal Osteoporosis Drug Key Countries Production Share
Table 2014-2019 Global Postmenopausal Osteoporosis Drug Key Countries Consumption Volume List
Figure 2014-2019 Global Postmenopausal Osteoporosis Drug Key Countries Consumption Volume
Table 2014-2019 Global Postmenopausal Osteoporosis Drug Key Countries Consumption Volume Share List
Figure 2014-2019 Global Postmenopausal Osteoporosis Drug Key Countries Consumption Volume Share
Figure 78 2014-2019 Global Postmenopausal Osteoporosis Drug Consumption Volume Market by Application
Table 89 2014-2019 Global Postmenopausal Osteoporosis Drug Consumption Volume Market Share List by Application
Figure 79 2014-2019 Global Postmenopausal Osteoporosis Drug Consumption Volume Market Share by Application
Table 90 2014-2019 Chinese Postmenopausal Osteoporosis Drug Consumption Volume Market List by Application
Figure 80 2014-2019 Chinese Postmenopausal Osteoporosis Drug Consumption Volume Market by Application
Figure 2019-2024 Global Postmenopausal Osteoporosis Drug Capacity Production and Growth Rate
Figure 2019-2024 Global Postmenopausal Osteoporosis Drug Production Value and Growth Rate
Table 2019-2024 Global Postmenopausal Osteoporosis Drug Capacity Production Cost Profit and Gross Margin List
Figure 2019-2024 Chinese Share of Global Postmenopausal Osteoporosis Drug Production
Table 2019-2024 Global Supply and Consumption of Postmenopausal Osteoporosis Drug
Table 2019-2024 Import and Export of Postmenopausal Osteoporosis Drug
Figure Industry Chain Structure of Postmenopausal Osteoporosis Drug Industry
Figure Production Cost Analysis of Postmenopausal Osteoporosis Drug
Figure Downstream Analysis of Postmenopausal Osteoporosis Drug
Table Growth of World output, 2014 – 2019, Annual Percentage Change
Figure Unemployment Rates in Selected Developed Countries, January 2014 – March 2018
Figure Nominal Effective Exchange Rate: Japan and Selected Emerging Economies, September 2014-March 2018
Figure 2014-2019 Chinese GDP and Growth Rates
Figure 2014-2019 Chinese CPI Changes
Figure 2014-2019 Chinese PMI Changes
Figure 2014-2019 Chinese Financial Revenue and Growth Rate
Figure 2014-2019 Chinese Total Fixed Asset Investment and Growth Rate
Figure 2019-2024 Chinese GDP and Growth Rates
Figure 2019-2024 Chinese CPI Changes
Table Economic Effects to Postmenopausal Osteoporosis Drug Industry
Table Postmenopausal Osteoporosis Drug Industry Development Challenges
Table Postmenopausal Osteoporosis Drug Industry Development Opportunities
Figure Map of Chinese 33 Provinces and Administrative Regions
Table Selected Cities According to Industrial Orientation
Figure Chinese IPR Strategy
Table Brief Summary of Suggestions
Table New Postmenopausal Osteoporosis Drugs Project Feasibility Study
世界の閉経後骨粗鬆症治療薬市場：市場規模・現状・予測 Osteoporosis is a disease where increased bone weakness increases the risk of a broken bone.The postmenopausal osteoporosis therapeutics market is expected to register a fast growth over the forecast period owing to the increasing prevalence of postmenopausal osteoporosis disease. In 2018, the globa…- 閉経後骨粗鬆症薬市場：世界及び中国市場分析・予測（～2024年） Postmenopausal Osteoporosis Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Postmenopausal Osteoporosis Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Po…
- 世界の骨粗鬆症治療薬市場：市場規模・現状・予測 Osteoporosis is a disease where decreased bone strength increases the risk of a broken bone. It is the most common reason for a broken bone among the elderly. Bones that commonly break include the back bones, the bones of the forearm, and the hip. Until a broken bone occurs there are typically no sy…
- 骨粗鬆症薬市場：世界及び中国市場分析・予測（～2024年） Osteoporosis Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Osteoporosis Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Osteoporosis Drugs manufacturers…
- リウマチ性障害薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Treatment of drugs for regulating rheumatic diseases Scope of the Report: Rheumatic diseases are a series of diseases characterized by chronic pain. Some of the most common diseases are osteoarthritis (OA) and rheumatoid arthritis (RA), and most rheumatic diseases use basically universal pain contro…